Skip to main content

Beneficial ownership — 13D / 13G

87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
VANGUARD GROUP INC CRI Carters Inc 13G/A 10.01% 2y
T. Rowe Price Investment Management, Inc. AMPL Amplitude, Inc. 13G/A 10.1% 2y
GATE CITY CAPITAL MANAGEMENT, LLC ALCO Alico, Inc. 13G/A 10.9% 2y
Driehaus Capital Management LLC AAOI Applied Optoelectronics, Inc. 13G/A 2.17% 2y
VANGUARD GROUP INC QCOM Qualcomm Inc 13G/A 10.03% 2y
GLAZER CAPITAL, LLC BOCN Blue Ocean Acquisition Corp Class A Ordinary Shares 13G 10.86% 2y
First Light Asset Management, LLC TELA TELA Bio, Inc. 13G/A 0% 2y
BIOTECHNOLOGY VALUE FUND L P CELC Celcuity Inc. 13G 9.9% 2y
Beryl Capital Management LLC SRDX Surmodics, Inc. Common Stock 13G 7.4% 2y
Madison Avenue Partners, LP MDRX Veradigm Inc. Common Stock 13G 5.7% 2y
Kunpeng Tech Limited KPEA Kun Peng International Ltd. 13D 10.86% 2y
Kun Peng XJ Limited KPEA Kun Peng International Ltd. 13D 9.98% 2y
Kungpeng TJ Limited KPEA Kun Peng International Ltd. 13D/A 21% 2y
Pui Chun Wong KPEA Kun Peng International Ltd. 13D/A 35.02% 2y
Lighthouse Investment Partners, LLC FRLA Fortune Rise Acquisition Corporation Class A Common Stock 13G/A 13.25% 2y
John J. Fisher GAP Gap Inc 13D/A 15.9% 2y
Soleus Capital Master Fund, L.P. TERN Terns Pharmaceuticals, Inc. 13G 5.2% 2y
Osmium Partners, LLC TBHC BRAND HOUSE COLLECTIVE, INC. 13D/A 9.7% 2y
Christopher D. Maggiore ZIVO Zivo Bioscience, Inc. 13D/A 14% 2y
Shasta Ventures II GP, LLC NXDR Nextdoor Holdings, Inc. 13D/A 4.7% 2y
Peter J. Werth CING Cingulate Inc. 13D/A 17.05% 2y
Saba Capital Management, L.P. GNT GAMCO Natural Resources, Gold & Income Trust 13D/A 10.7% 2y
GLOBAL VALUE INVESTMENT CORP. FLNT Fluent, Inc. 13D/A 7.26% 2y
J. Nicholas Ayers PSQH PSQ Holdings, Inc. 13D/A 4.4% 2y
Theofilos Charles Steve ECOR electroCore, Inc. 13D/A 6.5% 2y
PADDON PATRICK E CFNB California First Leasing Corp 13G 55.3% 2y
WPGG 14 Investment Ltd. IV DCBO Docebo Inc. 13G/A 10.41% 2y
PL Capital Advisors, LLC EVBN Evans Bancorp Inc 13D/A 11% 2y
BlackRock Inc. RIVN Rivian Automotive, Inc. 13G/A 4.7% 2y
BlackRock Inc. AAXJ iShares Trust 13G/A 0% 2y
BAILLIE GIFFORD & CO HCP HashiCorp, Inc. Class A Common Stock 13G/A 3.91% 2y
BlackRock Inc. FHI Federated Hermes, Inc. 13G/A 10.2% 2y
BlackRock Inc. FCNCA First Citizens Bancshares Inc 13G/A 10.7% 2y
BlackRock Inc. SRPT Sarepta Therapeutics, Inc. 13G/A 10.7% 2y
BlackRock Inc. AMG Affiliated Managers Group, Inc. 13G/A 10.2% 2y
BlackRock Inc. BAI BlackRock ETF Trust 13G/A 54.3% 2y
BlackRock Inc. AAXJ iShares Trust 13G/A 10.4% 2y
BlackRock Inc. COFS Choiceone Financial Services Inc 13G/A 4.97% 2y
JPMORGAN CHASE & CO CRI Carters Inc 13G/A 10.3% 2y
BAILLIE GIFFORD & CO DOCS Doximity, Inc. 13G/A 4.95% 2y
BlackRock Inc. AYI Acuity Inc. (De) 13G/A 10.7% 2y
BlackRock Inc. EBS Emergent BioSolutions Inc. 13G/A 12.7% 2y
Samir R. Patel AKTX Akari Therapeutics Plc 13D 14.5% 2y
METEORA CAPITAL, LLC IVCB Investcorp Europe Acquisition Corp I Class A Ordinary Shares 13G 11.07% 2y
BlackRock Inc. JOE ST JOE Co 13G/A 10.4% 2y
BlackRock Inc. POWW Outdoor Holding Co 13G/A 5% 2y
BlackRock Inc. AAXJ iShares Trust 13G/A 13.3% 2y
LFP Management, LLC INTS Intensity Therapeutics, Inc. 13G 5.4% 2y
Capital World Investors GTLS Chart Industries Inc 13G/A 4.7% 2y
JPMORGAN CHASE & CO NGL NGL Energy Partners LP 13G/A 4.1% 2y